Kidney cancer: Not a single disease [2]

Analytical and Quantitative Cytology and Histology

Volumn 29, Issue 6, 2007, Pages 377-379

  Pospihalj, Boris ^a   Zamparese, Rosanna ^b   Mazzucchelli, Roberta ^c   Morichetti, Doriana ^c  

^a General Hospital Celje   (Slovenia)

^b UNIVERSITY OF FOGGIA   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Cancer; Carcinoma; Kidney; Renal cell

Indexed keywords

TUMOR MARKER;

ACCURACY; CANCER STAGING; HUMAN; KIDNEY CANCER; KIDNEY CARCINOMA; LETTER; MICROSCOPY; MORPHOLOGY; NEEDLE BIOPSY; PRIORITY JOURNAL; PROGNOSIS;

CARCINOMA, RENAL CELL; CLINICAL TRIALS AS TOPIC; HUMANS; KIDNEY NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 37349043224     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (16)

1. Martignoni G, Brunelli M, Gobbo S, Remo A, Ficarra V, Cossu-Rocca P, Pea M, Chilosi M, Menestrina F, Cheng L: Role of molecular markers in diagnosis and prognosis of renal cell carcinoma. Anal Quant Cytol Histol 2007;29:41-49
2. Adley BP, Papavero V, Sugimura J, Teh BT, Yang XJ: Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Anal Quant Cytol Histol 2006;28:228-236
3. Reuter VE: The pathology of renal epithelial neoplasms. Semin Oncol 2006;33:534-543
4. Shuch BM, Lam JS, Belldegrun AS, Figlin RA: Prognostic factors in renal cell carcinoma. Semin Oncol 2006;33:563-575
5. McDermott DF, Atkins MB: Interleukin-2 therapy of metastatic renal cell carcinoma: Predictors of response. Semin Oncol 2006;33:583-587
6. Karakitsos P, Pouliakis A, Kordalis G, Georgoulakis J, Kittas C, Kyroudes A: Potential of radial basis function neural networks in discriminating benign from malignant lesions of the lower urinary tract. Anal Quant Cytol Histol 2005;27:35-42
7. Lee JS, Choi YD, Choi C, Lee MC, Park CS, Min KW: Expression of PTEN in ovarian epithelial tumors and its relation to tumor behavior and growth. Anal Quant Cytol Histol 2005;27:202-210
8. Lexander H, Palmberg C, Auer G, Hellstrom M, Franzen B, Jornvall H, Egevad L: Proteomic analysis of protein expression in prostate cancer. Anal Quant Cytol Histol 2005;27:263-272
9. Mazzucchelli R, Barbisan F, Stramazzotti D, Montironi R, Lopez-Beltran A, Scarpelli M: Chromosomal abnormalities in macroscopically normal urothelium in patients with bladder pT1 and pT2a urothelial carcinoma: A fluorescence in situ hybridization study and correlation with histologic features. Anal Quant Cytol Histol 2005;27:143-151
10. Nafe R, Yan B, Schlote W, Schneider B: Application of different methods for nuclear shape analysis with special reference to the differentiation of brain tumors. Anal Quant Cytol Histol 2006;28:69-77
11. Ozcan A, Deveci MS, Oztas E, Dede M, Yenen MC, Korgun ET, Gunhan O: Prognostic value of GLUT-1 expression in ovarian surface epithelial tumors: A morphometric study. Anal Quant Cytol Histol 2005;27:181-186
12. Sanseverino F, D'Andrilli G, Petraglia F, Giordano A: Molecular pathology of ovarian cancer. Anal Quant Cytol Histol 2005;27:121-124
13. Scartozzi M, Pierantoni C, Berardi R, Antognoli S, Bearzi I, Cascinu S: Epidermal growth factor receptor: A promising therapeutic target for colorectal cancer. Anal Quant Cytol Histol 2006;28:61-68
14. Tripp SR, Willmore-Payne C, Layfield LJ: Relationship between EGFR overexpression and gene amplification status in central nervous system gliomas. Anal Quant Cytol Histol 2005;27:71-78
15. Uccella S, Tibiletti MG, Bernasconi B, Finzi G, Oldrini R, Capella C: Aneuploidy, centrosome alteration and securin overexpression as features of pituitary somatotroph and lactotroph adenomas. Anal Quant Cytol Histol 2005;27:241-252
16. Choi HJ, Choi IH, Cho NH, Choi HK: Color image analysis for quantifying renal tumor angiogenesis. Anal Quant Cytol Histol 2005;27:43-51